Lobe Sciences Ltd. (CSE:LOBE)

Canada flag Canada · Delayed Price · Currency is CAD
0.0600
+0.0050 (9.09%)
At close: Feb 27, 2026
Market Cap16.17M +371.2%
Revenue (ttm)n/a
Net Income-4.54M
EPS-0.03
Shares Out269.49M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume41,000
Average Volume74,192
Open0.0600
Previous Close0.0550
Day's Range0.0600 - 0.0700
52-Week Range0.0200 - 0.1100
Beta-0.25
RSI54.31
Earnings DateApr 27, 2026

About Lobe Sciences

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol LOBE
Full Company Profile

Financial Performance

Financial Statements